Nari Talaty

Dr. Nari Talaty


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Analytical Chemistry
Verified
Journal Article
Open access
FPFan Pu
Fan Pu
SUScott A. Ugrin
Scott A. Ugrin
ARAndrew J. Radosevich
Andrew J. Radosevich
DCDavid Chang-Yen
David Chang-Yen
JSJames W. Sawicki
James W. Sawicki
JWJon D. Williams
Jon D. Williams
Mass spectrometry (MS) is the primary analytical tool used to characterize proteins within the biopharmaceutical industry. Electrospray ionization (ESI) coupled to liquid chromatography (LC) is the current gold standard for intact protein analysis. However, inherent speed limitations of LC/MS prevent analysis of large sample numbers (>1000) in a day. Infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI-MS), an ambient ionization MS technology, has recently been established as a platform for high-throughput small molecule analysis. Here, we report the applications of such a system for the analysis of intact proteins commonly performed within the drug discovery process. A wide molecular weight range of proteins 10-150 kDa was detected on the system with improved tolerance to salts and buffers compared to ESI. With high concentrations and model proteins, a sample rate of up to 22 Hz was obtained. For proteins at low concentrations and in buffers used in commonly employed assays, robust data at a sample rate of 1.5 Hz were achieved, which is ∼22× faster than current technologies used for high-throughput ESI-MS-based protein assays. In addition, two multiplexed plate-based high-throughput sample cleanup methods were coupled to IR-MALDESI-MS to enable analysis of samples containing excessive amounts of salts and buffers without fully compromising productivity. Example experiments, which leverage the speed of the IR-MALDESI-MS system to monitor NISTmAb reduction, protein autophosphorylation, and compound binding kinetics in near real time, are demonstrated.

18 April 2019 in Reaction Chemistry & Engineering
Verified
Journal Article
Closed access
PDF file
JSJames W. Sawicki
James W. Sawicki
ABAndrew R. Bogdan
Andrew R. Bogdan
PSPhilip A. Searle
Philip A. Searle
NTNari Talaty
Nari Talaty
SDStevan W. Djuric
Stevan W. Djuric
Application of high-speed DESI-MS analysis for the identification of optimal reaction conditions through high-throughput experimentation screening.

23 September 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ABAndrew Bowman
Andrew Bowman
JSJames Sawicki
James Sawicki
NTNari Talaty
Nari Talaty
WBWayne R. Buck
Wayne R. Buck
JYJunhai Yang
Junhai Yang
DWDavid Wagner
David Wagner
(1) Imaging of pharmaceutical compounds in tissue is an increasingly important subsection of Mass Spectrometry Imaging (MSI). Identifying proper target engagement requires MS platforms with high sensitivity and spatial resolution. Three prominent categories of drugs are small molecule drugs, antibody-drug conjugate payloads, and protein degraders. (2) We tested six common MSI platforms for their limit of detection (LoD) on a representative compound for each category: a Matrix-Assisted Laser Desorption/Ionization (MALDI) Fourier Transform Ion Cyclotron, a MALDI-2 Time-of-Flight (ToF), a MALDI-2 Trapped Ion Mobility Spectrometry ToF, a Desorption Electrospray Ionization Orbitrap, and 2 Atmospheric Pressure-MALDI Triple Quadrupoles. Samples were homogenized tissue mimetic models of rat liver spiked with known concentrations of analytes. (3) We found that the AP-MALDI-QQQ platform outperformed all 4 competing platforms by a minimum of 2- to 52-fold increase in LoD for representative compounds from each category of pharmaceutical. (4) AP-MALDI-QQQ platforms are effective, cost-efficient mass spectrometers for the identification of targeted analytes of interest.

7 October 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JYJunhai Yang
Junhai Yang
LRLauren Rendino
Lauren Rendino
SCSteven Cassar
Steven Cassar
WBWayne Buck
Wayne Buck
JSJames Sawicki
James Sawicki
DWDavid Wagner
David Wagner
The utility of zebrafish is becoming more frequent due to lower costs and high similarities to humans. Zebrafish larvae are attractive subjects for drug screening and drug metabolism research. However, obtaining good quality zebrafish larvae sections for batch samples at designated planes, angles, and locations for comparison purposes is a challenging task. We report here the optimization of fresh frozen zebrafish larvae sectioning for mass spectrometry imaging. We utilized the gelatin solutions that were created at two different temperatures (50 and 85 °C) as embedding media. Gelatin-50 (gelatin created under 50 °C, solid gel under room temperature) was used to make a larvae-shaped mold and gelatin-85 (gelatin created under 85 °C, liquid under room temperature) was used to embed the larvae. H&E staining of sections shows well-preserved morphology and minimal histological interference. More importantly, the position of the larvae was well controlled resulting in more consistent sectioning of the larvae.

5 June 2025 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YTYunsong Tong
Yunsong Tong
KBKenton A. Baker
Kenton A. Baker
ACAlex M. Chapman
Alex M. Chapman
NENathaniel L. Elsen
Nathaniel L. Elsen
FFFaith Fowler
Faith Fowler
AFAri J. Firestone
Ari J. Firestone

30 May 2023 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
NTNari Talaty
Nari Talaty
RJRobert W. Johnson
Robert W. Johnson
JSJames Sawicki
James Sawicki
ONOmprakash Nacham
Omprakash Nacham
SDStevan W. Djuric
Stevan W. Djuric